Wenyu Liu

Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS.

X. Chen, Jianda Hu, Z. Ge, 2022, Clinical lymphoma, myeloma & leukemia.

Coumarinolignans Isolated from the Seeds of Brucea javanica

Shucai Li, Huan Tang, A. Peng, 2014 .

Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.

Kihyun Kim, Je-Jung Lee, Tianyuan Zhou, 2023, Clinical lymphoma, myeloma & leukemia.

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.

Xiao-jun Huang, Z. Cai, Jie Jin, 2021, Clinical lymphoma, myeloma & leukemia.